Vital Therapies reported $104.76M in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Biomarin Pharmaceutical BMRN:US $ 2517.6M 123.57M
Dynavax Technologies DVAX:US $ 955.4M 14.89M
Enanta Pharmaceuticals ENTA:US $ 313.04M 28.83M
Epizyme EPZM:US $ 186.84M 41.87M
Insmed INSM:US $ 674.73M 81.41M
Intercept Pharmaceuticals ICPT:US $ 487.02M 9.66M
Mirati Therapeutics MRTX:US $ 1202.93M 140.19M
Omeros OMER:US $ 192.72M 17.5M
Orasure Technologies OSUR:US $ 267.31M 1.06M
Quidel QDEL:US $ 1559.1M 554.55M
Regulus Therapeutics RGLS:US $ 51.4M 6.54M
Revance Therapeutics RVNC:US $ 260.94M 24.38M
Ultragenyx Pharmaceutical RARE:US $ 678.54M 28.98M
United Therapeutics UTHR:US $ 2684.3M 97.7M
Vital Therapies VTL:US $ 104.76M 11.12M
Xoma XOMA:US $ 87.26M 2.35M